Is sentinel node biopsy necessary in the radiologically negative axilla in breast cancer? Felix JozsaMuneer AhmedMichael Douek Editorial 31 May 2019 Pages: 1 - 4
Yoga has a solid effect on cancer-related fatigue in patients with breast cancer: a meta-analysis Bei DongCongyan XieLi Tian Review 24 May 2019 Pages: 5 - 16
Prognostic role of immune infiltrates in breast ductal carcinoma in situ Xiao-Yang ChenJoe YeongPuay Hoon Tan Review 27 May 2019 Pages: 17 - 27
Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists Erik HedrickXi LiStephen Safe Preclinical study 22 May 2019 Pages: 29 - 40
Breast cancer outcome prediction with tumour tissue images and machine learning Riku TurkkiDmitrii ByckhovNina Linder Preclinical study Open access 22 May 2019 Pages: 41 - 52
Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors: B-ABLE cohort study Marta Pineda-MoncusÃSonia ServitjaXavier Nogués Preclinical study 24 May 2019 Pages: 53 - 60
Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy Melissa Krystel-WhittemoreJin XuHannah Y. Wen Preclinical study 29 May 2019 Pages: 61 - 66
The impact of distinct triple-negative breast cancer subtypes on misdiagnosis and diagnostic delay C. ElfgenZ. VargaU. Güth Preclinical study 01 June 2019 Pages: 67 - 75
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome Cody PlastererShirng-Wern TsaihMichael J. Flister Preclinical study 04 June 2019 Pages: 77 - 91
Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT) Bassam BasulaimanArif Ali AwanMark Clemons Clinical trial 24 May 2019 Pages: 93 - 101
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial Matteo LambertiniChristine CampbellEvandro de Azambuja Clinical trial 27 May 2019 Pages: 103 - 114
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study Manuel RuÃz-BorregoAngel Guerrero-ZotanoGEICAM Clinical trial 31 May 2019 Pages: 115 - 125
Sharing in care: engaging care partners in the care and communication of breast cancer patients Jennifer L. WolffJennifer AufillAntonio C. Wolff Clinical trial 04 June 2019 Pages: 127 - 136
Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer? Maria K. PomponioLuke J. KeeleJulia C. Tchou Epidemiology 22 May 2019 Pages: 137 - 143
Assessment of PARP4 as a candidate breast cancer susceptibility gene Aldo PrawiraPrabhakaran MunusamyAnn Siew Gek Lee Epidemiology 22 May 2019 Pages: 145 - 153
The effect of local therapy on breast cancer-specific mortality of women with occult breast cancer and advanced nodal disease (N2/N3): a population analysis Helen M. JohnsonWilliam IrishJan H. Wong Epidemiology 24 May 2019 Pages: 155 - 164
Combined effect of volumetric breast density and body mass index on breast cancer risk Natalie J. EngmannChristopher G. ScottKarla Kerlikowske Epidemiology 25 May 2019 Pages: 165 - 173
The use of contralateral prophylactic mastectomy among elderly patients in the United States Schelomo MarmorAriella M. AltmanTodd M. Tuttle Epidemiology 28 May 2019 Pages: 175 - 183
Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database Thomas HellandKari Britt HagenGunnar Mellgren Epidemiology 29 May 2019 Pages: 185 - 195
Patterns of relapse after neoadjuvant chemotherapy in breast cancer: implications for surveillance in clinical practice Stephanie SawJohn LimYoon Sim Yap Epidemiology 30 May 2019 Pages: 197 - 206
Employment trends in young women following a breast cancer diagnosis Shoshana M. RosenbergInes Vaz-LuisAnn H. Partridge Epidemiology 30 May 2019 Pages: 207 - 214
Is immediate breast reconstruction safe in women over 70? An analysis of the National Surgical Quality Improvement Program (NSQIP) database Fernando A. AngaritaFahima DossaTulin D. Cil Epidemiology 01 June 2019 Pages: 215 - 224
Radiation oncology crossword: breast cancer Shearwood McClelland IIIRyan M. RhomeRichard C. Zellars Brief Report 01 June 2019 Pages: 225 - 230
What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy? Roberta MaltoniSara Bravaccini Letter to the Editor 22 May 2019 Pages: 231 - 232
ER(+)/HER2(+) and ER−/HER2(+) breast cancers might have different intracranial recurrence patterns after brain-directed radiation for brain metastases Kadri Altundag Letter to the Editor 25 May 2019 Pages: 233 - 233
Correction to: Racial disparities in surveillance mammography among older breast cancer survivors Jimmitti TeysirNana GegechkoriJenny J. Lin Correction 05 June 2019 Pages: 235 - 236
